IT1257345B - Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione. - Google Patents

Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione.

Info

Publication number
IT1257345B
IT1257345B ITGE920060A ITGE920060A IT1257345B IT 1257345 B IT1257345 B IT 1257345B IT GE920060 A ITGE920060 A IT GE920060A IT GE920060 A ITGE920060 A IT GE920060A IT 1257345 B IT1257345 B IT 1257345B
Authority
IT
Italy
Prior art keywords
solution
procedure
iatrogen
injury
produce
Prior art date
Application number
ITGE920060A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITGE920060A priority Critical patent/IT1257345B/it
Publication of ITGE920060A0 publication Critical patent/ITGE920060A0/it
Priority to ES93108735T priority patent/ES2152235T3/es
Priority to DE69329435T priority patent/DE69329435T2/de
Priority to EP93108735A priority patent/EP0572963B1/en
Publication of ITGE920060A1 publication Critical patent/ITGE920060A1/it
Application granted granted Critical
Publication of IT1257345B publication Critical patent/IT1257345B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • External Artificial Organs (AREA)

Abstract

Soluzione sclerosante ottenuta sciogliendo in acqua bidistillata acido salicilico e carbonato sodico oppure sodio salicilato dal 3% al 12% e glicerolo dal 10% al 60%.Procedimento per ottenere detta soluzione.La soluzione viene prodotta con mezzi sterili in ambiente sterile oppure sterilizzata in autoclave.
ITGE920060A 1992-06-02 1992-06-02 Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione. IT1257345B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITGE920060A IT1257345B (it) 1992-06-02 1992-06-02 Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione.
ES93108735T ES2152235T3 (es) 1992-06-02 1993-05-31 Solucion esclerosante.
DE69329435T DE69329435T2 (de) 1992-06-02 1993-05-31 Sklerosierende Lösung
EP93108735A EP0572963B1 (en) 1992-06-02 1993-05-31 Sclerosing solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITGE920060A IT1257345B (it) 1992-06-02 1992-06-02 Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione.

Publications (3)

Publication Number Publication Date
ITGE920060A0 ITGE920060A0 (it) 1992-06-02
ITGE920060A1 ITGE920060A1 (it) 1993-12-02
IT1257345B true IT1257345B (it) 1996-01-15

Family

ID=11354281

Family Applications (1)

Application Number Title Priority Date Filing Date
ITGE920060A IT1257345B (it) 1992-06-02 1992-06-02 Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione.

Country Status (4)

Country Link
EP (1) EP0572963B1 (it)
DE (1) DE69329435T2 (it)
ES (1) ES2152235T3 (it)
IT (1) IT1257345B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290439B1 (it) * 1997-03-25 1998-12-03 Marcello Izzo Medicamento ad attivita' sclerosante
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
ES2216708B1 (es) * 2003-04-08 2006-02-16 Antonio Luis Cabrera Garrido "solucion esclerosante".
IT201800001122A1 (it) * 2018-01-16 2019-07-16 Sergio Capurro Composizione volta a realizzare la tecnica della flebo terapia rigenerativa tridimensionale per il trattamento della malattia varicosa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016264A (en) * 1975-07-14 1977-04-05 The University Of Utah Wart treatment with phosphonoacetic acid or derivatives thereof
JPS62106022A (ja) * 1985-11-02 1987-05-16 Nasa:Kk 動物用皮膚真菌症速効性治療薬液
WO1990009779A1 (en) * 1989-02-28 1990-09-07 Benhuri Marc N Method and composition for treatment of periodontal disease

Also Published As

Publication number Publication date
DE69329435T2 (de) 2001-04-19
ES2152235T3 (es) 2001-02-01
ITGE920060A0 (it) 1992-06-02
EP0572963B1 (en) 2000-09-20
ITGE920060A1 (it) 1993-12-02
EP0572963A3 (it) 1994-03-23
DE69329435D1 (de) 2000-10-26
EP0572963A2 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
BR9908043A (pt) Dispositivo médico de biomaterial colagenosomulti-formado
AR074958A2 (es) Composicion farmaceutica liofilizada de anticuerpos monoclonales o policlonales y procedimiento para su produccion
DK0738106T3 (da) Sterilisering med pereddikesyre
ES2054649T3 (es) 2-aminotetralinas basicas substituidas.
DE69316170D1 (de) Orale Formulierung zum verbesserten Bleichen von Zähnen
AR031108A1 (es) Un metodo para mejorar la actividad de una sal de aluminio o de aluminio/circonio que contiene especies de aluminio pequenas y grandes, las sales asi obtenidas y los productos antitranspirantes y/o desodorantes preparados con dichas sales mejoradas
ES2175825T3 (es) Antitraspirante con dibencilidensorbitol.
TR200003315T2 (tr) Acil durumda kullanılmaya uygun yeni farmasötik terkip ve bunun hazırlanma yöntemi
MX170909B (es) Procedimiento para preparar un agente para la deteccion y determinacion de actividad de peroxidasa, producto resultante y su empleo
ES2036576T3 (es) Barra desodorante transparente.
ES2163461T3 (es) Procedimiento para la obtencion de comprimidos efervescentes.
ES2134189T3 (es) Procedimiento para la preparacion de un producto de celulosa oxidado neutralizado y uso del mismo.
ATE3241T1 (de) Verfahren zur herstellung einer waessrigen dialyseloesung.
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
IT1257345B (it) Soluzione sclerosante, ad elevata efficacia, che non produce lesioni iatrogene e procedimento per ottenere tale soluzione.
ES2015901B3 (es) Procedimiento para el aislamiento y purificacion de la hemina.
NZ500288A (en) Gastric-retained pharmaceutical composition comprising benzamide as the active principle and a carbon dioxide generating system
ES2060417T3 (es) Procedimiento para la preparacion por compresion directa de comprimidos de derivados del acido cefalosporanico.
IT8468029A1 (it) Sistema laser particolarmente per chirurgia oftalmologica.
RO79975A (ro) Sistem de schimburi de mesaje codificate intre statii
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
EA200100785A1 (ru) Шипучие слабительные средства
GR77250B (it)
ES509470A0 (es) "procedimiento para la preparacion de soluciones acuosas de metioninato de sodio".
DK401683D0 (da) Substituerede benzensulfonsyreestere, fremgangsmade til deres fremstilling og deres anvendelse som laegemidler

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970627